The University of Queensland

Protocol NV17317 - Peginterferon alfa-2a & Ribavirin (2003–2004)

Grant type:

Roche Products Pty Ltd

Researchers:

• 

  Associate Professor Graeme Macdonald

  ATH - Professor
  

  Princess Alexandra Hospital Southside Clinical Unit

  Faculty of Medicine

Funded by:

Roche Products Pty Ltd